Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
227.99
-0.26 (-0.11%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,554,692
Open
228.78
Bid (Size)
227.80 (1)
Ask (Size)
228.47 (1)
Prev. Close
228.25
Today's Range
226.25 - 229.04
52wk Range
163.81 - 244.81
Shares Outstanding
N/A
Dividend Yield
2.88%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Prediction: These Dividend Stocks Could Outperform Growth Stocks in the Next Decade
October 26, 2025
Between growth and dividends, these companies have plenty to offer.
Via
The Motley Fool
Topics
Economy
Intellectual Property
ONEOK’s 6% Dividend Draws Smart Money Despite a Nearly 30% Drop
October 23, 2025
ONEOK’s 6% Dividend Draws Smart Money Despite a Nearly 30% Drop
Via
The Motley Fool
Topics
Energy
Regulatory Compliance
Performance
YTD
+27.1%
+27.1%
1 Month
+3.3%
+3.3%
3 Month
+20.9%
+20.9%
6 Month
+18.5%
+18.5%
1 Year
+20.2%
+20.2%
More News
Read More
Why Some Investors Are Taking Profits on JPMorgan After Its Big Rally
October 23, 2025
Via
The Motley Fool
AbbVie Draws Growing Institutional Confidence As Investors Seek Steady Growth
October 23, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
3 Pharmaceutical Growth Stocks to Buy and Hold for 10 Years
October 23, 2025
Via
MarketBeat
Bullish Bet: Investment Manager Makes Strategic Buy of Prologis Stock
October 23, 2025
Via
The Motley Fool
Topics
Economy
Regulatory Compliance
Blue Owl Capital Stock Trimmed by Investment Manager, According to Recent Filing
October 23, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Investment Manager Doubles Down on Regional Bank Stock, According to Recent Filing
October 23, 2025
Via
The Motley Fool
Topics
Credit Cards
Regulatory Compliance
Motley Fool Co-Founder Tom Gardner: The Quarterly Call
October 22, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
AbbVie: Navigating Challenges and Seizing Opportunities in the Pharma Sector
October 22, 2025
Via
The Motley Fool
Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence
October 22, 2025
Via
MarketMinute
Qualcomm, Aptiv, Palo Alto And A Health Care Stock On CNBC's 'Final Trades'
October 22, 2025
Via
Benzinga
This Florida Fund Is Betting $21 Million on Vertiv as AI Data Center Growth Accelerates
October 21, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Supply Chain
Abacus FCF Advisors Bets $16 Million on Hilton Even as Hotel Stock Lags Market
October 21, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Why This Florida Fund Locked In DoorDash Gains After a 70% Stock Surge
October 21, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Florida Fund Takes $17 Million Stake in Tapestry Amid Luxury Retail Stock's Big Rally
October 21, 2025
Via
The Motley Fool
Novo Nordisk Hires US Pharma Veteran After Trump Touts ‘Much Lower’ Prices Of Ozempic
October 17, 2025
Via
Stocktwits
Topics
Government
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
October 16, 2025
Via
The Motley Fool
3 Top Dividend Growth Stocks to Buy Right Now
October 15, 2025
Via
The Motley Fool
Amazon, AbbVie, Datadog And A Financial Stock: CNBC's 'Final Trades'
October 14, 2025
Via
Benzinga
2 Profitable Stocks to Research Further and 1 We Avoid
October 14, 2025
Via
StockStory
If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today
October 13, 2025
Via
Benzinga
VIX Roars Back: Trade Tensions Ignite "Fear Gauge," Signaling Potential Market Shift
October 13, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
ETFs
AbbVie Stock Rises After FDA Approves Changed Recommendations For Use Of Popular Rinvoq Drug
October 13, 2025
Via
Stocktwits
2 Dividend Stocks to Double Up on Right Now
October 13, 2025
Via
The Motley Fool
Topics
Economy
Intellectual Property
World Trade
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 227.99
When was AbbVie last traded?
The last trade of AbbVie was at 10/24/25 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.